Abstract
SARS-CoV-2 showed how measures against airborne pathogens are critical in clinical environments. Bacteria make no exception. Healthcare-associated or Hospital-Acquired Infections (HAIs) represent one of the major concerns in the Western world, impairing the clinical outcome of up to 15% of all hospitalized patients [1]. Every year in the European community about 3.2 million patients acquire a HAI, and 37,000 die as a direct consequence of HAI, and the presence of Multi-Drug Resistant (MDR) bacteria is a growing concern [1,2].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Biomedical Research & Environmental Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
